KKR buys majority stake in health software company Therapy Brands
Global investment firm KKR plans to acquire a majority stake in health software company Therapy Brands. PSG, a previous investor in the company, will remain a minority shareholder.
Consumer awareness, needs generating shifts in precision medicine landscape
Healthcare consumers are increasingly aware of specific therapies in development or on the market that can help treat the diseases they or their loved ones may be suffering from — and this growing awareness is changing the precision medicine arena.
Take the 2025 Benefit Consultant Sentiment Index Survey
If you’re helping clients navigate big changes—from the surge in GLP-1 demand to AI to the growing pressure to demonstrate ROI – we want your thoughts.
BridgeBio Pharma raises $299.2M in financing round
The company sources product candidates from academic and commercial research and then launches subsidiary companies to develop them.
Clarify Health nabs $57M for care guidance tech and clinical trial expansion
San Francisco-based Clarify Health's new funding round led by private equity firm KKR will help the company build out data science expertise, buy data assets and enter the life sciences sector.
KKR’s $2.8B WebMD acquisition and how searching for health information has evolved
WebMD's acquisition calls to mind just how much the business of online searches for health information has evolved.
Spirox closes $45M Series C for its device used by Ear, Nose and Throat physicians
Nasal obstruction is a significant problem that effects more than three million Americans each year. Spirox is developing a minimally invasive device that would decrease the need for surgery.
Tackling Rising Drug Costs and Growing Popularity of GLP-1’s
See how Quantum Health is providing the steps to help their members tackle the cost of specialty medications and other drugs.